Skip to search formSkip to main contentSkip to account menu

BAEC protocol

Known as: BEAC protocol, ARA-C/BCNU/CTX/VP-16, Carmustine/Cyclophosphamide/Cytarabine/Etoposide 
National Institutes of Health

Related topics

Related topics

5 relations

Broader (4)

Antineoplastic Combined Chemotherapy ProtocolsCarmustineCyclophosphamideEtoposide
Cytarabine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Treatment of Recurrent Posttransplant Lymphoproliferative Disorder with Autologous Blood Stem Cell Transplant
Background. Posttransplant lymphoproliferative disorders (PTLDs) occur after solid organ transplantation. Treatment guidelines… 
2010
2010
Pegfilgrastim appears equivalent to daily dosing of filgrastim to treat neutropenia after autologous peripheral blood stem cell transplantation in patients with non-Hodgkin lymphoma.
BACKGROUND Filgrastim decreases the time to neutrophil recovery after autologous peripheral blood stem cell transplantation… 
2010
2010
Excessive toxicity of once daily i.v. BU, melphalan and thiotepa followed by auto SCT on patients with non-Hodgkin's lymphoma
Excessive toxicity of once daily i.v. BU, melphalan and thiotepa followed by auto SCT on patients with non-Hodgkin's lymphoma 
Highly Cited
2000
Highly Cited
2000
eNOS-overexpressing endothelial cells inhibit platelet aggregation and smooth muscle cell proliferation in vitro.
Endothelial cell seeding of synthetic small diameter vascular grafts (SSDVG) has been shown to diminish thrombosis and intimal… 
2000
2000
Long‐term follow‐up of autologous stem‐cell transplantation for follicular and transformed follicular lymphoma
Abstract: Despite the fact that follicular lymphomas are both chemo‐ and radiosensitive, the disease is generally non‐curable… 
1998
1998
Second neoplasms following high-dose chemotherapy and autologous stem cell transplantation for malignant lymphomas: a report of six cases in a cohort of 171 patients from a single institution.
High dose chemotherapy with autologous stem cell transplantation (ASCT) is increasingly used in the treatment of patients with… 
Highly Cited
1997
Highly Cited
1997
Autotransplantation for relapsed or refractory non-Hodgkin’s lymphoma (NHL): long-term follow-up and analysis of prognostic factors
One hundred and thirty-six patients autografted for relapsed or refractory non-Hodgkin’s lymphoma (NHL) were evaluated to assess… 
Review
1995
Review
1995
Hemolytic uremic syndrome after high dose chemotherapy with autologous stem cell support
Background. Chemotherapy intensification may lead to new forms of toxicity such as hemolytic uremic syndrome. 
1994
1994
Leukocyte-reduced transfusions of ABO-identical platelets and clinical outcome in autologous bone marrow transplantation for lymphoma.
In observational studies, use of ABO-identical platelets and leukocyte-reduced blood components have been associated with… 
Highly Cited
1991
Highly Cited
1991
Parma international protocol: pilot study of DHAP followed by involved-field radiotherapy and BEAC with autologous bone marrow transplantation.
Fifty patients with intermediate- or high-grade non-Hodgkin's lymphoma (NHL) who had relapsed after a complete remission induced… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)